Fortrea Holdings Inc. (FTRE)

Market Cap	711.87M
Revenue (ttm)	2.73B
Net Income (ttm)	-1.03B
Shares Out	90.80M
EPS (ttm)	-11.40
PE Ratio	n/a
Forward PE	14.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,799,798
Open	7.21
Previous Close	7.31
Day's Range	7.20 - 7.95
52-Week Range	3.97 - 25.28
Beta	1.80
Analysts	Hold
Price Target	14.70 (+86.79%)
Earnings Date	Aug 6, 2025

About FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I – IV clinical trial management, clinical phar...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 16,120
• Stock Exchange: NASDAQ
• Ticker Symbol: FTRE
• Website: https://www.fortrea.com

Financial Performance

In 2024, Fortrea Holdings's revenue was $2.70 billion, a decrease of -5.14% compared to the previous year's $2.84 billion. Losses were -$328.50 million, 1203.6% more than in 2023.

Analyst Forecast

According to 11 analysts, the average rating for FTRE stock is "Hold." The 12-month stock price target is $14.7, which is an increase of 86.79% from the latest price.

Price Target

$14.7

(86.79% upside)

Analyst Consensus: Hold